for those who've asked what exactly my use of *line in the
for those who've asked what exactly my use of *line in the sand* refers to:
the way it works ..
entity enters an OTC stock .. with 2 crews (most are interchangeable)
one side works what i call the PRO side .. the other side works the CON side
entity front loads then runs OTC stock utilizing PRO side
entity then undertakes the *short* in the OTC stock (CON side)
depending on various aspects (SS legitimacy et al) there may be more than 1 RUN
b4 the final *KILL* for profit order is executed
the problem entity encountered with P2O ran across multiple levels
not the least of which was an *initial* inability to access P2O certs in 2010
that inability set up 4+ years of *efforts* to force out legit sellers of significance
2 years ago .. *entities* line in the sand was 1.50 to 1.65 which i noted *there*
one can observe the rather curious reality of dolt's settlement and the RUN
on PTOI to 1.49
after of course an aromatic sold *mere* days b4 said settlement @ approx 77c
suspect this *aromatic* and others (of the colluding variety) were responsible
for threshold being triggered on PTOI for the second time (June 2012 .. 10 days)
realize within mere days of dolt's settlement RUN .. resetting via compression
of PTOI was back in play (as it had been with that one exception since mid 2012)
fingers point to *collusion* specific to who *entered* P2O in 2012
so if in 2012 and 2013 .. entities' line in the sand was 1.50 to 1.65
what did it become after 18 to 19 months of non stop compression via resets?
my thinking in mid Sept 2014 .. was 35 to 55c (approx) .. it's why in mgmt's shoes
and recognizing *entity* was on their knees .. i would have 8k'd the national co.
by the EO the 3rd Q (9.30.14) >> UPDATE
i would never have allowed this FILTH to *rebreak* 10c on PTOI
since then (2+ months ago) and clearly since *volume* undertaken on 10.9 and 10.10.14
that rivals 1.4.12 and 1.5.12 .. in volume only
it's become quite clear that the *new* short (ie line in their sand) is far lower
than 35 to 55c ..
15c .. is now most likely 10c
now this isn't retail .. because they all collude (yep every one of your brokerage firms
will loan out your PTOI *shares* if they can get away with it which because of that T + 3 .. they can .. for a PRICE)
but *original + added colluding entities* >> are stuck in a dilemma of their own making
they have 2 choices .. keep reducing PPS on PTOI (which i've shown isn't working)
ATS DATA POST >> dated data but showing an increase re: total lack of traction (ie that volume didn't come from
a legit seller of PTOI .. rather a cert was accessed hoping to create FEAR)
Plastic2Oil, Inc. (PTOI) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...
Continue Reading
Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...
Continue Reading
The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...
Continue Reading
Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...
Continue Reading
Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...
Continue Reading
Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...
Continue Reading
The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...
Continue Reading
A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...
Continue Reading
Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...
Continue Reading
In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...
Continue Reading
Top 5 Most Recently Viewed Articles
Héroux-Devtek Gains Court Approval for Acquisition Héroux-Devtek Inc. (TSX: HRX), a well-known name in the aerospace industry, has recently received approval from the Superior Court of Québec for its acquisition by an affiliate of Platinum Equity Advisors, LLC. This approval represents a significant step forward for the company, which is recognized around the world as...
Continue Reading
Understanding Share Capital and Voting Rights of VINCI VINCI, a prominent French public limited company known for its extensive infrastructure projects, boasts a significant share capital valued at €1,474,737,915.00. This capital structure is crucial as it reflects the financial backbone of the organization, enabling it to undertake various development and construction...
Continue Reading
Overview of Middlefield Canadian Income PCC Middlefield Canadian Income PCC is a protected cell company that has been incorporated in Jersey. It is recognized for its strategic investments which cater to various market needs. With a legal entity identifier, 2138007ENW3JEJXC8658, it offers a structured approach to investment management. Latest Net Asset Value Information...
Continue Reading
AgEagle Aerial Systems Reigns Supreme in the Drone Market AgEagle Aerial Systems Inc., a prominent name in the unmanned aerial system (UAS) sector, has recently achieved a remarkable milestone. According to an extensive analysis of the Federal Aviation Administration (FAA) Part 107 registration data conducted from 2021 onwards, the company’s eBee is recognized as the...
Continue Reading
Sapphire Foods Facing Tough Times Amid Sales Declines Sapphire Foods India Ltd (SAPPHIRE:IN) is currently experiencing significant pressure on its stock prices due to disappointing sales figures, particularly from its KFC brand. Recent adjustments by analysts from BofA Securities have downgraded the company's price target to INR 325.00, down from INR 330.00, while...
Continue Reading